CSIMarket
 


Proteo Inc  (PTEO)
Other Ticker:  
 
 

PTEO's Income from Cont. Operations Growth by Quarter and Year

Proteo Inc's Income from Cont. Operations results by quarter and year




PTEO Income from Cont. Operations (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - -0.10 -0.12 -0.11
III Quarter September - -0.02 -0.01 -0.06
II Quarter June - -0.07 0.08 -0.02
I Quarter March -0.05 -0.03 0.10 0.06
FY   -0.05 -0.22 0.05 -0.13



PTEO Income from Cont. Operations first quarter 2020 Y/Y Growth Comment
Proteo Inc in the first quarter 2020 recorded loss from continued operations of $ -0.05 millions.

According to the results reported in the first quarter 2020, Proteo Inc achieved the best Income from Cont. Operations growth in Major Pharmaceutical Preparations industry. While Proteo Inc' s Income from Cont. Operations no change of % ranks overall at the positon no. in the first quarter 2020.




PTEO Income from Cont. Operations ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - 66.67 % -
FY   - - - -

Financial Statements
Proteo Inc's first quarter 2020 Income from Cont. Operations $ -0.05 millions PTEO's Income Statement
Proteo Inc's first quarter 2019 Income from Cont. Operations $ -0.03 millions Quarterly PTEO's Income Statement
New: More PTEO's historic Income from Cont. Operations Growth >>


PTEO Income from Cont. Operations (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - -20 % -
I Quarter March - - - -
FY (Year on Year)   - - - -




Income from Cont. Operations first quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Income from Cont. Operations first quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Income from Cont. Operations by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Proteo Inc's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PTEO's I. Quarter Q/Q Income from Cont. Operations Comment
Even if Proteo Inc in the I. Quarter 2020 revealed loss from continued operations of $ -0.05 millions, it should be said, that current results point to slight up side in contrast to the -0.10 millions in the fourth quarter.

Within Major Pharmaceutical Preparations industry Proteo Inc achieved highest sequential Income from Cont. Operations growth. While Proteo Inc's Income from Cont. Operations growth quarter on quarter, overall rank is .


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PTEO's I. Quarter Q/Q Income from Cont. Operations Comment
Although Proteo Inc in the I. Quarter 2020 showed loss from continued operations of $ -0.05 millions, it should be said, that those numbers show improvement compare to the -0.10 millions in the fourth quarter.

Within Major Pharmaceutical Preparations industry Proteo Inc achieved highest sequential Income from Cont. Operations growth. While Proteo Inc's Income from Cont. Operations growth quarter on quarter, overall rank is .


Proteo Inc's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
Cumulative Income from Cont. Operations 12 Months Ending $ -0.23 $ -0.22 $ -0.25 $ -0.23 $ -0.09
Y / Y Income from Cont. Operations Growth (TTM) - - - - -
Year on Year Income from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential Income from Cont. Operations Change (TTM) - - - - -
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative Income from Cont. Operations growth Comment
Proteo Inc' has realized cumulative trailing twelve months loss from continued operations of $ 0 millions in the Mar 31 2020 period.
The situation is getting worse as the cumulative loss from continued operations is inflating from $ -0.22 millions in TTM ending quarter Dec 31 2019 and $ 0.039241 millions for the twelve months ending in the quarter Mar 31 2019 Jacob Jones told.

Proteo Inc achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Income from Cont. Operations growth Comment
Proteo Inc' has realized cumulative trailing twelve months loss from continued operations of $ 0 millions in the Mar 31 2020 period.
The results are worsening as the cumulative loss from continued operations is getting bigger from $ -0.22 millions in the twelve months ending a quarter before and $ 0.039241 millions from the TTM period ending Mar 31 2019 Jacob Jones told.

Proteo Inc achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Income from Cont. Operations Growth
Major Pharmaceutical Preparations Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
PTEO's Income from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for PTEO's Competitors
Income from Cont. Operations Growth for Proteo Inc's Suppliers
Income from Cont. Operations Growth for PTEO's Customers

You may also want to know
PTEO's Annual Growth Rates PTEO's Profitability Ratios PTEO's Asset Turnover Ratio PTEO's Dividend Growth
PTEO's Roe PTEO's Valuation Ratios PTEO's Financial Strength Ratios PTEO's Dividend Payout Ratio
PTEO's Roa PTEO's Inventory Turnover Ratio PTEO's Growth Rates PTEO's Dividend Comparisons



Companies with similar Income from Cont. Operations no change for the quarter ending Mar 31 2020 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Mar 31 2020
Msa Safety Incorporated87.38%$ 87.380 millions
Electromed Inc 86.57%$ 86.572 millions
Addus Homecare Corporation78.07%$ 78.075 millions
Nature s Sunshine Products inc 73.86%$ 73.858 millions
Davita Inc 73.21%$ 73.208 millions
Perrigo Company Plc66.51%$ 66.510 millions
Pro dex Inc 65.71%$ 65.710 millions
Corcept Therapeutics Inc64.52%$ 64.523 millions
Tenax Therapeutics Inc 64.13%$ 64.126 millions
Quidelortho Corp61.96%$ 61.959 millions
Resmed Inc 54.76%$ 54.755 millions
Johnson and Johnson54.60%$ 54.601 millions
Medpace Holdings Inc 50.82%$ 50.818 millions
Ensign Group Inc49.24%$ 49.241 millions
3m Company44.90%$ 44.905 millions
Semler Scientific Inc 44.17%$ 44.175 millions
National Research Corporation43.42%$ 43.424 millions
Iqvia Holdings Inc 35.82%$ 35.821 millions
Zoetis Inc 35.58%$ 35.577 millions
Regeneron Pharmaceuticals Inc 35.46%$ 35.459 millions
West Pharmaceutical Services Inc 34.12%$ 34.116 millions
Select Medical Holdings Corp32.06%$ 32.064 millions
Meridian Bioscience Inc 31.93%$ 31.928 millions
Masimo Corp30.68%$ 30.684 millions
China Health Industries Holdings Inc 29.27%$ 29.273 millions
Anika Therapeutics Inc 28.53%$ 28.533 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com